|
⚲
|
| Keyboard |
| Daigneault Alessandra
✚
|
|
|---|---|
| CIK # | 0001864648 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001864648] | |
| 4 | [0001864648] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Daigneault Alessandra | |
| NRX Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option (Right to buy) · derivative
|
2021-09-02 | Conversion | 28,916 | $3.07 | 88,772 |
|
NRX Pharmaceuticals Inc NRXP
Restricted Stock Units · derivative
|
2021-09-02 | Grant | 7,502 | $0.00 | |
|
NRX Pharmaceuticals Inc NRXP
Restricted Stock Units · derivative
|
2021-09-02 | Grant | 10,496 | $0.00 | |
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option (Right to buy) · derivative
|
2021-09-02 | Conversion | 20,666 | $3.07 | 63,445 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-09-02 | Option exercise | 13,164 | $3.07 | 40,413 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-09-02 | Option exercise | 18,420 | $3.07 | 56,549 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-08-23 | Sell | 33,715 | $13.11 | 442,004 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-08-19 | Option exercise | 27,395 | $3.07 | 84,103 |
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option (Right to buy) · derivative
|
2021-08-19 | Conversion | 43,000 | $3.07 | 132,010 |
|
NRX Pharmaceuticals Inc NRXP
Restricted Stock Units · derivative
|
2021-08-19 | Grant | 15,605 | $0.00 | |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-05-24 | Grant | 6,320 | ||
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option (Right to buy) · derivative
|
2021-05-24 | Grant | 143,840 | ||
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option (Right to buy) · derivative
|
2021-05-24 | Grant | 148,800 | ||
|
NRX Pharmaceuticals Inc NRXP
Employee Stock Option (Right to buy) · derivative
|
2021-05-24 | Grant | 49,600 |